Douglas Elliman (NYSE: DOUG) swings to a Q3 profit, but adjusted EBITDA slips to a loss

What happened

Douglas Elliman Inc. (NYSE: DOUG) swung to third-quarter net income of $7.4 million from a net loss of $24.7 million a year earlier. Revenue fell, and a litigation benefit sits inside the improvement. Holders have to judge how much of the rebound will last.

Diluted earnings were $0.08 per share, against a loss of $0.29 in the third quarter of 2025. Operating income was $6.3 million, compared with an operating loss of $10.7 million.

Key numbers

Metric	Latest	Change	Source
Q3 net income attributed to Douglas Elliman	$7.4 million	from -$24.7 million, +$32.1 million	Calculated from SEC 8-K
Q3 operating income	$6.3 million	from -$10.7 million, +$17.0 million	Calculated from SEC 8-K
Q3 revenue	$252.1 million	from $262.8 million, -4.1%	Calculated from SEC 8-K
Q3 adjusted EBITDA attributed to Douglas Elliman	-$5.3 million	from $1.0 million, -$6.3 million	Calculated from SEC 8-K
Cash, equivalents and U.S. Treasury Bill, Sept. 30, 2026	about $123 million		SEC 8-K Exhibit 99.1
Share repurchase authorization (cap)	up to $10 million		SEC 8-K Exhibit 99.1

Read more: Douglas Elliman (DOUG) company research

Where the profit came from

Revenue was $252.1 million, down from $262.8 million. The prior-year figure includes property management, which the company sold in October 2025. Without it, that revenue was $253.4 million. By OptimistFi's calculation, underlying revenue slipped $1.3 million, or 0.5%, against a 4.1% drop in the reported figure.

Costs moved most. General and administrative expense fell to $1.5 million from $32.2 million. This quarter's figure includes a net litigation and settlement benefit of $15.4 million. A year earlier, that item was a net expense of $5.8 million. The year-earlier quarter also carried a charge for the change in fair value of a derivative embedded in convertible debt.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

Why it matters

OptimistFi has argued that Douglas Elliman's stock works only if the profit rebound is a durable recovery in transaction economics. This quarter gives mixed evidence.

Activity held up. Gross transaction value was about $10.0 billion in both third quarters. The average price per transaction rose to $1.83 million from $1.77 million. Transactions fell to 5,494 from 5,661.

The measures that remove one-time items are weaker. Adjusted EBITDA attributed to the company was a loss of $5.3 million, against income of $1.0 million a year earlier. Adjusted net loss widened to $8.0 million from $1.4 million.

The longer view points the same way. Net income for the twelve months ended Sept. 30, 2026 was $57.0 million, but the reconciliation removes an $82.1 million gain on the sale of a business. Adjusted EBITDA attributed to the company for that period was a loss of $27.3 million, against a loss of $14.0 million for 2025.

Over nine months, the net loss narrowed to $11.6 million from $53.3 million. Adjusted EBITDA attributed to the company still worsened, to a loss of $16.7 million from $3.4 million.

Cash, the buyback and the pipeline

The balance sheet gives the company room. As of Sept. 30, 2026, cash and cash equivalents were $102.7 million. It also held a $20 million U.S. Treasury Bill and had no long-term debt, for about $123 million in total.

The board authorized repurchases of up to $10 million of common stock. That is a cap, not a commitment. The company says it need not buy any particular amount and may change or suspend the program. Purchases are expected to come from cash on hand. About 91 million shares were outstanding as of Nov. 4.

The company cites a development marketing pipeline of $26.0 billion, with another $11.8 billion scheduled to come to market through Dec. 31, 2027. It expects its AI work to gradually cut non-commission operating expenses over the next three years, with savings beginning in 2027.

What's next

Management discusses the results on a conference call and webcast on Tuesday, Nov. 10, at 8:00 a.m. ET. A replay stays available through Nov. 24. The company expects the non-commission expense savings to begin in 2027. Narrowing adjusted EBITDA losses as those savings arrive would support the rebound case. Continued losses would weaken it.

More from OptimistFi

• DOUG stock: research and coverage of Douglas Elliman
• Stock research on every company OptimistFi covers

From OptimistFi Perps